Welcome to the e-CCO Library Archive!
T. Shepherd1, E. Cronin1, K. Greveson1, O. Epstein1, G. Erian1, F. Jaboli1, E. Despott1, M. Hamilton1, C. Murray1, 1Royal Free Hospital, Gastroenterology, London, United Kingdom
Withdrawing or continuing maintenance treatment with thiopurines in patients with Crohn's Disease in sustained clinical remission: a lifetime risk-benefit analysis
J. Kirchgesner*1, 2, F. Carrat2, 3, J. Cosnes1, M. Schwarzinger4, L. Beaugerie1, For the BERENICE Study Group1
1Hopital Saint Antoine, Department of Gastroenterology, Paris, France, 2INSERM, University Paris 06 , UMR S 1136 , Paris, France, 3Hopital Saint Antoine, Department of Public Health, Paris, France, 4THEN, Translational Health Economics Network, Paris, France
Rate of and response to dose escalation in paediatric patients with Crohn's disease from IMAgINE 1
M. Dubinsky1, J. Rosh2, W.A. Faubion3, J. Kierkus4, F. Ruemmele5, J. Hyams6, S. Eichner7, Y. Li7, A. Lazar8, R.B. Thakkar7, 1Cedars-Sinai Medical Center, Pediatric Inflammatory Bowel Disease Program, Los Angeles, United States, 2Goryeb Children's Hospital/Atlantic Health, Pediatric Gastroenterology, Morristown, United States, 3Mayo Clinic, Gastroenterology, Rochester, United States, 4The Children's Memorial Health Institute, Gastroenterology, Hepatology and Feeding Disorders, Warsaw, Poland, 5Universite Sorbonne Paris-Cite, Hospital Necker-Enfants Malades, APHP, Paris, France, 6Connecticut Children's Medical Center, Division of Digestive Diseases, Hartford, United States, 7AbbVie Inc, GPRD, North Chicago, United States, 8AbbVie Deutschland GmbH & Co, KG, GPRD, Ludwigshafen, Germany
T. Tandiari1, G. Eslick2, R. Leong1, 1Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia, 2The Whiteley-Martin Research Centre, Gastroenterology, Sydney, Australia
Dietary fiber intake in children with Inflammatory Bowel Disease
A. Pituch-Zdanowska, A. Banaszkiewicz, P. Albrecht*
Medical University of Warsaw, Dept. of Pediatric Gastroenterology and Nutrition, Warsaw, Poland
Rare skin disorders in IBD patients treated with anti-TNFs
V. Prieto1,2, A. Fernandez1, A. Velasco1, C. Piñero1, J. Umaña1, Y. Jamanca1, A. Mora1, A. Rodriguez1, 1Hospital Clínico de Salamanca, Gastroenterology, Salamanca, Spain, 2Hospital Clínico de Salamanca, Medicine, Salamanca, Spain
C.K. Lee1, H.-S. Kim2, H.-J. Kim1, W. Moon3, K.M. Lee4, J.-S. Koo5, G.S. Seo6, S.J. Park7, B.D. Ye8, C.H. Choi9, S.-A. Jung10, Y.S. Kim11, J.P. Im12, E.S. Kim13, S.N. Hong14, 1Kyung Hee University, South Korea, 2Yonsei University Wonju College of Medicine, South Korea, 3Kosin University, South Korea, 4The Catholic University of Korea, South Korea, 5Korea University, South Korea, 6Wonkwang University, South Korea, 7Yonsei University, South Korea, 8University of Ulsan, South Korea, 9Chung-Ang University, South Korea, 10Ewha Womans University, South Korea, 11Inje University, South Korea, 12Seoul National University, South Korea, 13Keimyung University, South Korea, 14Konkuk University, South Korea
Ustekinumab in super-refractory Crohn´s disease patients
C. Herrera*, V. Robles, C. Jimenez, E. Navarro, F. Casellas, N. Borruel
Unitat Atenció Crohn-Colitis. Hospital Universitari Vall d'Hebron, Digestive System Research Unit, Barcelona, Spain
Rapid infusion, high dose ferric carboxymaltose in the treatment of iron deficiency in paediatric inflammatory bowel disease – a single centre experience
N. Carman, R. Muir, P. Lewindon, Royal Children's Hospital, Gastroenterology Department, Brisbane, Australia
M.J. Carrillo1, R. Beltrán1, B. Maldonado1, C. Duarte1, L. Castro1, F. Argüelles1, A. Benitez1, A. Caunedo1, F. Pellicer1, J.M. Herrerias1, 1Hospital Virgen Macarena, Sevilla, Spain
Diffusion-Weighted magnetic resonance enterocolonography before treatment predicts remission after anti-TNF therapy in Crohn's disease
A. Buisson*1, 2, C. Hordonneau3, M. Goutte1, 2, J. Scanzi1, F. Goutorbe1, T. Klotz3, L. Boyer3, B. Pereira4, G. Bommelaer1, 2
1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the host, Clermont-Ferrand, France, 3University Hospital Estaing, Radiology Department, Clermont-Ferrand, France, 4GM – Clermont-Ferrand University and Medical Center, , Biostatistics Unit , Clermont-Ferrand, France
Prospective withdrawal trial of azathioprine (AZA) in ulcerative colitis (UC)
C. Pratico', N. Capozzi, F. Rizzello, A. Calafiore, R. Brugnera, G. Straforini, G. Spuri Fornarini, M. Campieri, C. Calabrese, P. Gionchetti, University of Bologna, Internal Medicine, Bologna, Italy